Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

on Also in ,
Swiss drugmaker Novartis gets go-ahead from U.S. regulators to conduct tests of malaria drug against COVID-19.

Share:

Previous
Next

Comentarios

Publicar un comentario

Leave a comment. Thanks!

Comentarios de Facebook

Suscribirse a: Enviar comentarios (Atom)